Skip to main content

Latest Market News — Page 121

Page 121 · 30 stories scored 7+ · newest 4:39 PM ET · How scores work

Thu, Aug 1330 stories
7GEMIGemini Space Station, Inc.Gemini Space Station Q2 Revenue Jumps 37% but $16M Fraud Provision Hits Bottom LineEarnings & guidance · Reuters▼ Negative7ZNTLZentalis Pharmaceuticals, Inc.Zentalis Launches Underwritten Public Offering, Diluting Existing HoldersFinancing · Reuters▼ Negative8BZAIBlaize Holdings, Inc.Blaize Slashes 2026 Revenue Outlook on Slower Orders, Higher Memory CostsEarnings & guidance · Reuters▼ NegativePro8SRTSSensus Healthcare, Inc.Sensus Healthcare Q2 Revenue Misses by 50% as Unit Sales FallEarnings & guidance · Reuters▼ NegativePro8VMETVersamet Royalties CorpVersamet Royalties Posts Record Q2: Revenue Up 392%, GEOs Up 256%Earnings & guidance · TMX Newsfile▲ PositivePro8LRCXLam Research CorporationLam Research to Invest $3B+ in Global R&D Lab Expansion to Speed AI Chip InnovationProduct & regulatory · PR Newswire▲ PositivePro7KLCKinderCare Learning Companies, Inc.KinderCare Q2 Misses on Lower Enrollment, Guides 2026 EPS to $0.05-$0.15Earnings & guidance · Reuters▼ Negative7DAREDare Bioscience, Inc.Dare Bioscience Q2 Loss Narrows, First Commercial Product LaunchesEarnings & guidance · Reuters▲ Positive7NKTRNEKTAR THERAPEUTICSNektar Q2 Revenue Falls to $10.1M, Net Loss Narrows to $40.6MEarnings & guidance · Reuters● Neutral7JCAPJefferson Capital, Inc.Jefferson Capital Q2 Revenue Beats on Strong Collections and Bluestem DealEarnings & guidance · Reuters▲ Positive8DLOdLocal LtddLocal Q2 Profit Soars 28% to $127M, Crushing EstimatesEarnings & guidance · Reuters▲ PositivePro7IVVDInvivyd, Inc.Invivyd Q2 Loss Widens to $44M, Misses Estimates on Higher Trial CostsEarnings & guidance · Reuters▼ Negative7GLOBGlobant S.A.Globant Q2 EPS Misses, Guides Q3 Revenue Down 1.6% at MidpointEarnings & guidance · Reuters▼ Negative7ENSCEnsysce Biosciences, Inc.Ensysce Q2 Loss Widens to $2.6M, But $31M Cash Boost Extends Runway to 2027Earnings & guidance · Reuters▼ Negative7TPSTTempest Therapeutics, Inc.Tempest Unveils 100% CR Rate in CAR-T Trials, New China PartnershipEarnings & guidance · GlobeNewswire▲ Positive7GNSSGenasys Inc.Genasys Q3 Revenue Misses by 63% as Supply Chain Delays BiteEarnings & guidance · Reuters▼ Negative8QSIQuantum-Si IncQuantum-Si Slashes 20% of Workforce, Delays Proteus Launch to 2027 as Revenue Plunges 42%Earnings & guidance · Reuters▼ NegativePro7XELBXCel Brands, Inc.Xcel Brands Q2 Revenue Misses by 38% on Judith Ripka DivestitureEarnings & guidance · Reuters▼ Negative8YSSYork Space Systems Inc.York Space Cuts FY Revenue Outlook as Government Awards SlowEarnings & guidance · Reuters▼ NegativePro7FFAIFaraday Future Intelligent Electric Inc.Faraday Future Posts $17.38 Q2 Loss Per ShareEarnings & guidance · Dow Jones Newswires▼ Negative8XOSXos, Inc.Xos Q2 Revenue Misses by 67% as Deliveries Slip to Later QuartersEarnings & guidance · Reuters▼ NegativePro7RKDAArcadia Biosciences, Inc.Arcadia Biosciences Q2 Net Loss Widens to $6.27M on Financing Valuation LossEarnings & guidance · Reuters▼ Negative7EQEquillium, Inc.Equillium Q2 Loss Narrows to $4.69M, Beats Estimates; New R&D Programs AdvanceEarnings & guidance · Reuters▲ Positive7VUZIVuzix CorpVuzix Q2 Revenue Falls 14% as R&D Spending ClimbsEarnings & guidance · Reuters● Neutral7GNLXGENELUX CorpGenelux Q2 Loss Widens to $9.5M; Phase 3 Ovarian Cancer Data Due 2H26Earnings & guidance · GlobeNewswire▼ Negative9ETONEton Pharmaceuticals, Inc.Eton Pharmaceuticals Q2 EPS Crushes Estimates, Raises 2026 Revenue Guidance to Over $145MEarnings & guidance · Reuters▲ PositivePro7MSAIMultiSensor AI Holdings, Inc.MultiSensor AI Q2 Revenue Jumps 19% to $1.7M, Loss Narrows 26%Earnings & guidance · Reuters▲ Positive7IDNIntellicheck, Inc.Intellicheck Q2 Revenue Beats, But Major Customer Shift Clouds OutlookEarnings & guidance · Reuters● Neutral7DWSNDAWSON GEOPHYSICAL CODawson Geophysical Q2 Revenue Jumps 82% on New Equipment DeploymentEarnings & guidance · Reuters▲ Positive7ICCCImmuCell CorporationImmuCell Q2 Net Income Hits $1.8M on Legal Settlement, Plans $8M Capacity ExpansionEarnings & guidance · Reuters▲ Positive
How Wiseek picks and scores these

How Wiseek curates this list

Every entry started life as licensed wire-service reporting (Reuters, Dow Jones Newswires, and similar publishers) covering ticker-attributable events. Wiseek's editorial pipeline ingests these in real time, runs each headline through our domain-tuned importance scorer, and surfaces only items rated 7 or higher on a 1–10 market-impact scale. Items below 7 are filtered out at the database query so the public feed stays signal-dense.

What "AI-ranked analysis" means

For each item we publish a plain-English summary, a sentiment label (positive / negative / neutral), and a structured list of key events extracted from the underlying source. Score, summary, and sentiment come from Wiseek's in-house models — not generic chatbot output. See our methodology for the full pipeline and our editorial policy for source-attribution standards.

What's not on this page

Generic market commentary, opinion columns, low-impact press releases, and items below the 7-point importance threshold. Wiseek aggregates and scores wire-service headlines; the underlying publishers retain their original reporting and are credited per article.

Track by company

Follow SEC filings and market news for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.